| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/03/2007 | CN1889237A Method for using special chelant for micro electronic |
| 01/03/2007 | CN1887885A Reactive metal phthalocyanine derivative and its prepn |
| 01/03/2007 | CN1887828A Synthesis process of 18F lebeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst |
| 01/03/2007 | CN1293078C Imidazo fused compounds |
| 01/03/2007 | CN1293059C New Carboxglic acid derivative, its preparation and application |
| 01/03/2007 | CN1293057C Ethylenediamine derivatives |
| 01/02/2007 | US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions |
| 01/02/2007 | US7157578 4-(2-butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-YL) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 01/02/2007 | US7157490 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/02/2007 | US7157468 Pyrazole derivatives |
| 01/02/2007 | US7157460 Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | CA2177602C N-substituted azabicycloalkane derivatives, their preparation and use |
| 12/28/2006 | WO2006138734A1 Triazolopyrimidine cannabinoid receptor 1 antagonists |
| 12/28/2006 | WO2006138682A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 12/28/2006 | WO2006138657A1 Bicyclic heterocycles as cannabinoid-1 receptor modulators |
| 12/28/2006 | WO2006138656A2 Bicyclic heterocycles as cannabinoid-1 receptor modulators |
| 12/28/2006 | WO2006138453A2 Compositions and methods pertaining to pna synthons and oligomers comprising a universal base |
| 12/28/2006 | WO2006138357A1 Macrocyclic metal complexes for their use as anticancer agents |
| 12/28/2006 | WO2006138264A2 Aspartyl protease inhibitors |
| 12/28/2006 | WO2006138218A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 12/28/2006 | WO2006138217A1 Aspartyl protease inhibitors |
| 12/28/2006 | WO2006138195A1 Macrocyclic heterocyclic aspartyl protease inhibitors |
| 12/28/2006 | WO2006138192A1 Aspartyl protease inhibitors |
| 12/28/2006 | WO2006137791A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 12/28/2006 | WO2006136866A1 Process for enantiomeric separation of zopiclone |
| 12/28/2006 | WO2006136530A1 Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates |
| 12/28/2006 | WO2006136442A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 12/28/2006 | WO2006136005A1 Purine derivatives and their use for treatment of autoimmune diseases |
| 12/28/2006 | WO2006107273A8 Compounds having progestogenic activity and their use |
| 12/28/2006 | WO2006009789A3 Aryl-substituted piperazine derivatives |
| 12/28/2006 | US20060293521 Including polyether substituents including pendant alkoxy fluoroalkyl groups; for wetting, leveling and flow agents in solvent-borne coating systems |
| 12/28/2006 | US20060293517 Enantiomerically pure cilazapril, process for preparation |
| 12/28/2006 | US20060293357 Chemical intermediates for indole alkaloids, formed by cyclization of thioanilides, then chlorination of indole derivatives with t-butylhypochlorite, coupling vindolines, deacetylation and desulfonation; anticarcinogrnic agents |
| 12/28/2006 | US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/28/2006 | US20060293347 Pharmaceutically active compounds |
| 12/28/2006 | US20060293345 Heterobicyclic metalloprotease inhibitors |
| 12/28/2006 | US20060293337 P2x7 receptor antagonists and their use |
| 12/28/2006 | US20060293335 Riboflavin derivative and its manufacture and uses |
| 12/28/2006 | US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase |
| 12/28/2006 | US20060293331 Process of synthesizing tadalafil |
| 12/28/2006 | US20060293330 Hiv replication inhibiting purine derivatives |
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | US20060293305 5-(2-amino-5-oxo-1,5-dihydro-imidazol-4-ylidene)-3,4,5,10-tetrahydro-2H-azepino[3,4-b]indol-1-one, used for treating inflammatory disorders selected from arthritis, inflammatory bowel disease, asthma, dermatitis and transplant rejection; inhibiting production of a cytokine in cells; enzyme inhibitors |
| 12/28/2006 | US20060293249 Porphyrin derivatives |
| 12/28/2006 | US20060292570 Novel synthetic binding pairs and uses thereof |
| 12/28/2006 | US20060292494 Novel phthalocyanine derivatives, synthetic process thereof and their applications in optical recording media |
| 12/28/2006 | US20060292072 Agents for neutron capture therapy |
| 12/28/2006 | US20060289313 Reactive oxygen species measuring device |
| 12/28/2006 | CA2612763A1 Process for enantiomeric separation of zopiclone |
| 12/28/2006 | CA2612726A1 Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates |
| 12/28/2006 | CA2610828A1 Heterocyclic aspartyl protease inhibitors, preparation and use thereof |
| 12/28/2006 | CA2610815A1 Aspartyl protease inhibitors |
| 12/28/2006 | CA2610812A1 Aspartyl protease inhibitors |
| 12/28/2006 | CA2610742A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 12/28/2006 | CA2610617A1 The preparation and use of protease inhibitors |
| 12/28/2006 | CA2609582A1 Aspartyl protease inhibitors |
| 12/28/2006 | CA2609562A1 Macrocyclic heterocyclic aspartyl protease inhibitors |
| 12/28/2006 | CA2608314A1 Purine derivatives and their use for treatment of autoimmune diseases |
| 12/27/2006 | EP1736475A1 Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates |
| 12/27/2006 | EP1736468A2 Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1735320A1 Compounds and methods for treating dyslipidemia |
| 12/27/2006 | EP1735316A2 6-(2,6-dichlorophenyl)-triazolopyrimidines, methods for the production thereof, use thereof for controlling pathogenic fungi, and agents containing the same |
| 12/27/2006 | EP1735315A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS |
| 12/27/2006 | EP1735314A1 Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor |
| 12/27/2006 | EP1735309A1 An improved process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides |
| 12/27/2006 | EP1735307A1 Inhibitors of iap |
| 12/27/2006 | EP1735280A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
| 12/27/2006 | EP1735269A1 Process for the preparation of enantiomerically enriched beta amino acid derivatives |
| 12/27/2006 | EP1734951A2 Diphenyl-indol-2-on compounds and their use in the treatment of cancer |
| 12/27/2006 | EP1734825A1 5,6-cycloalkyl-7-aminotriazolopyrimidines, method for production and use thereof for the prevention of fungal pests and agents comprising the same |
| 12/27/2006 | EP1734820A2 Imidazopyrazines, imidazopyridines, and imidazopyrimidines as crf1 receptor ligands |
| 12/27/2006 | EP1608317A4 Dipeptidyl peptidase inhibitors |
| 12/27/2006 | EP1597260B1 Triazole compounds useful in therapy |
| 12/27/2006 | EP1585748B1 PYRAZOLO 3,4-d PYRIMIDINE DERIVATIVES AND THEIR USE I N THE TREATMENT OF H.PYLORI INFECTION |
| 12/27/2006 | EP1436267B1 Lactam derivatives as antagonists for human 11cby receptors |
| 12/27/2006 | EP1381604B1 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 12/27/2006 | EP1226144B1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 12/27/2006 | EP1149118B1 Method of producing derivatized polymers |
| 12/27/2006 | EP0638123B1 Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form |
| 12/27/2006 | CN1886407A Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 12/27/2006 | CN1886405A Pyrrolo-pyrazine derivatives useful as CB1-modulators |
| 12/27/2006 | CN1886404A 6-(2,4,6-trifluorophenyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and substances containing the same |
| 12/27/2006 | CN1886197A Pentasil-structuer zeolithic material, the production and use thereof |
| 12/27/2006 | CN1884285A Copper phthalocyanine liquid solid phase mixed type continuous reactor and its process |
| 12/26/2006 | US7153975 Boron complexation strategy for use in manipulating 1-acyldipyrromethanes |
| 12/26/2006 | US7153967 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates |
| 12/26/2006 | US7153963 Phenylalanine derivatives |
| 12/26/2006 | US7153961 Hydrate of a benzenesulfonate salt of 4-(bis(2-methoxyethyl)amino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-[1,5-a]-pyrazolo-1,3,5-triazine; physical and chemical properties that are both physiologically acceptable and suitable for preparing reproducible pharmaceutical formulations |
| 12/26/2006 | US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 12/26/2006 | US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 12/26/2006 | US7153956 To provide IR dyes and inks tuned to near-IR wavelengths and, additionally, to provide near-IR dyes that are water-dispersible |
| 12/26/2006 | US7153882 (Aminocarbonyloxy)-benzofused ring derivatives; Alzheimer*s disease; neurodegenerative disorders |
| 12/26/2006 | US7153873 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 12/26/2006 | US7153872 Cancer and fibrotic diseases |
| 12/26/2006 | US7153860 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 12/26/2006 | US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease |
| 12/26/2006 | US7153854 Pyrrolopyridazine derivatives |